1,058
Views
5
CrossRef citations to date
0
Altmetric
Research Paper

Immunization rates of pneumococcal, influenza and tetanus vaccines and knowledge and attitudes of adult patients who receive inpatient treatment at hospital: Point prevalence study

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 2649-2653 | Received 14 Feb 2018, Accepted 30 May 2018, Published online: 12 Jul 2018

References

  • Maltezou HC, Wicker S, Borg M, Heininger U, Puro V, Theodoridou M, Poland GA. Vaccination policies for health-care workers in acute health-care facilities in Europe. Vaccine. 2011;29:9557−62. doi:10.1016/j.vaccine.2011.09.076. PMID: 21964058.
  • Williams WW, Lu PJ, O'Halloran A, Kim DK, Grohskopf LA, Pilishvili T, Skoff TH, Nelson NP, Harpaz R, Markowitz LE et al. Surveillance of vaccination coverage among adult populations – United States, 2015. MMWR SurveillSumm. 2017;66:1−28. doi:10.15585/mmwr.ss6611a1. PMID: 28472027.
  • Swanson KA, Schmitt HJ, Jansen KU, Anderson AS. Adult vaccination. Hum Vaccin Immunother. 2015;11:150−5. doi:10.4161/hv.35858. PMID: 25483533
  • Alici DE, Sayiner A, Unal S. Barriers to adult immunization and solutions: personalized approaches. Hum Vaccin Immunother. 2017;13:213−15. doi:10.1080/21645515.2016.1234556. PMID: 27669411.
  • Centers for Disease Control and Prevention (CDC). Use of 13-valent pneumococcal conjugate vaccineand 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816−9. PMID: 23051612.
  • Shields GE, Elvidge J, Davies LM. A systematic review of economic evaluations of seasonal influenza vaccination for the elderly population in the European Union. BMJ Open. 2017;7:e014847. doi:10.1136/bmjopen-2016-014847. PMID:28601824
  • Kim DK, Bridges CB, Harriman KH; Advisory committee on Immunization Practices (ACIP), ACIP Adult Immunization work group. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older – United States, 2016. Am J Transplant. 2016;16:1930−32. doi:10.1111/ajt.13877. PMID: 27197898
  • Lee HJ, Choi JH. Tetanus-diphtheria-acellular pertussis vaccination for adults: an update. Clin Exp Vaccine Res. 2017;6:22−30. doi:10.7774/cevr.2017.6.1.22. PMID: 28168170.
  • Klett-Tammen CJ, Krause G, Seefeld L, Ott JJ. Determinants of tetanus, pneumococcal and influenza vaccination in the elderly: a representative cross-sectional study on knowledge, attitude and practice (KAP). BMC Public Health.2016;16:121. doi:10.1186/s12889-016-2784-8. PMID: 26846202.
  • Urun Y, Akbulut H, Demirkazik A, Cay Senler F, Utkan G, Onur H, Icli F. Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members. J BUON. 2013;18:511−5.
  • Çelebi Sözener Z, Mısırlıgil M, Çerçi P, Aydın Ö, Kendirlinan R, Sin B, Mısırlıgil Z. Attitudes of adult asthma patients towards influenza vaccination. Tuberk Toraks. 2016; 64:269−74. doi:10.5578/tt.42397. PMID: 28366139.
  • Satman I, Akalin S, Cakir B, Altinel S; diaVAXStudyGroup. Theeffect of physicians' awareness on influenza and pneumococcal vaccination rates and correlates of vaccination in patients with diabetes in Turkey: an epidemiological Study “diaVAX”. Hum Vaccin Immunother. 2013;9:2618−26. Epub 2013 Jul 25. doi:10.4161/hv.25826. PMID: 23887188.
  • Kaufman Z, Green MS. Compliance with influenza and pneumococcal vaccinations in Israel, 1999–2002. Public Health Rev. 2003;31:71−9. PMID: 14656044.
  • Nuorti JP, Butler JC, Farley MM, Harrison LH, McGeer A, Kolczak MS, Breiman RF. Cigarette smoking and invasive pneumococcal disease. Active bacterial core surveillance team. N Engl J Med. 2000;342:681−9. doi:10.1056/NEJM200003093421002. PMID: 10706897.
  • Zangwill KM, Vadheim CM, Vannier AM, Hemenway LS, Greenberg DP, Ward JI. Epidemiology of invasive pneumococcal disease in southern California: implications for the design and conduct of a pneumococcal conjugate vaccine efficacy trial. J Infect Dis. 1996;174:752−9. doi:10.1093/infdis/174.4.752. PMID:8843213.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.